FDA Warns of Amputations Connected to Certain Diabetes Drugs

Posted by Firm Staff on Jun 15, 2017 10:48:27 AM

Serious side effects, including leg, foot, and other amputation, have been associated with a new class of diabetes drugs known as SGLT-2 inhibitors. Accordingly, the FDA has required black boxed warnings for amputation risks for glucose-controlling medications such as Invokana.

Read More

Topics: Health News, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Amputation, Amputation Compensation, Amputation Attorney, Amputation Law, Amputation Lawyer, Amputation Lawsuit, Leg Amputation, Leg Amputation Compensation, Leg Amputation Attorney, Leg Amputation Law, Leg Amputation Lawyer, Leg Amputation Lawsuit, Foot Amputation, Foot Amputation Compensation, Foot Amputation Attorney, Foot Amputation Law, Foot Amputation Lawyer, Foot Amputation Lawsuit, Invokana, Invokana Compensation, Invokana Attorney, Invokana Law, Invokana Lawyer, Invokana Lawsuit, Diabetes Drug, Diabetes Drug Lawsuit, Type 2 Diabetes, Type 2 Diabetes Medication, Diabetes Medication, SGLT-2 Inhibitors, SGLT-2 Inhibitors Lawsuit

Research Finds Risk of Heart Attack Higher in Pradaxa Users

Posted by Firm Staff on May 16, 2017 1:27:17 PM

A study published by CBS News finds Pradaxa users at a 33% higher risk of developing heart disease or heart attack when compared to warfarin users. An editorial accompanying this study notes this isn’t the first safety warning issued for the anti-clotting drug Pradaxa.

Read More

Topics: Health News, Health, Health Study, Health Research, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Pradaxa, Pradaxa Lawsuit, Pradaxa Law, Pradaxa Lawyer, Pradaxa Attorney, Stroke

How Accurate were Xarelto Clinical Trial Results? A CBS News Investigation

Posted by Firm Staff on Apr 25, 2017 7:29:02 PM

Xarelto is a blood thinning medication used to treat atrial fibrillation in people who are also at risk for stroke. However, multiple lawsuits have been filed against the manufacturer of Xarelto claiming the company withheld important safety information.

Read More

Topics: Health News, Health, Health Study, Health Research, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Xarelto, Xarelto Lawsuit

ABC News: Levaquin Labels Don’t Fully Explain Risks of Use

Posted by Firm Staff on Apr 18, 2017 1:17:26 PM

According to plaintiffs in a federal lawsuit filed in the District of Columbia, pharmaceutical giant Johnson & Johnson, the manufacturer of Levaquin, hid details about the drug’s adverse side effects.

Read More

Topics: Fluoroquinolone, Fluoroquinolones, Levaquin, Avelox, FDA, Health, Medical Update, Levaquin Lawsuit, Avelox Lawsuit, FLQ, FLQ Lawsuit, Fluoroquinolone Lawsuit, Fluoroquinolones Lawsuit, Ryan Foster, Foster & Houston, The Law Offices of Foster & Houston, Avelox Law, Levaquin Law, Avelox Lawyer, Levaquin Lawyer, Levaquin Attorney, Avelox Attorney

Pradaxa Can Increase Risk of Stroke, Bleeding, Hematomas, and More

Posted by Firm Staff on Apr 3, 2017 3:39:27 PM

The FDA has issued a medication guide about the risks associated with the blood-thinner medication Pradaxa. Side effects associated with the drug include uncontrollable bleeding, hematomas, stroke and death.

Read More

Topics: Health News, Health, Health Study, Health Research, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Pradaxa, Pradaxa Lawsuit, Pradaxa Law, Pradaxa Lawyer, Pradaxa Attorney, Stroke

Disabling Side Effects Linked to Levaquin and Avelox

Posted by Firm Staff on Mar 10, 2017 5:07:06 PM

Serious side effects, including aortic aneurysm and long-term nerve damage, have been associated with a class of antibiotics called fluoroquinolones. Accordingly, the FDA has strengthened label warnings for bacteria-fighting drugs such as Levaquin and Avelox.

Read More

Topics: Fluoroquinolone, Fluoroquinolones, Levaquin, Avelox, FDA, Health, Medical Update, Levaquin Lawsuit, Avelox Lawsuit, FLQ, FLQ Lawsuit, Fluoroquinolone Lawsuit, Fluoroquinolones Lawsuit, Ryan Foster, Foster & Houston, The Law Offices of Foster & Houston, Avelox Law, Levaquin Law, Avelox Lawyer, Levaquin Lawyer, Levaquin Attorney, Avelox Attorney

Increased Risk of Cleft Palate Associated with Zofran

Posted by Firm Staff on Feb 21, 2017 3:21:56 PM

Based on the data available today, Zofran use during pregnancy cannot be assumed to be safe, claims the National Center for Biotechnology Information. In fact, a case-control study suggested there was an increased risk of cleft palate associated with Zofran.

Read More

Topics: Health, Zofran, Medical, Medical News, FDA, Zofran Lawsuit, Ryan Foster, Foster & Houston, The Law Offices of Foster & Houston, FANDHLAW

Xarelto Can Increase Risk of Bleeding, Hematomas, Stroke and More

Posted by Firm Staff on Feb 9, 2017 7:08:00 PM

 

Read More

Topics: Health News, Health, Health Study, Health Research, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Xarelto, Xarelto Lawsuit

Harvard Health: Higher Bleeding Risk Associated with Pradaxa

Posted by Firm Staff on Jan 23, 2017 3:32:33 PM

A study covered in the Harvard Health Publications blog finds Pradaxa users have a higher bleeding risk compared to Warfarin users. In this post, Howard LeWine, M.D., discusses Pradaxa research and shares his professional opinion about blood-thinners.

Read More

Topics: Health News, Health, Health Study, Health Research, Ryan Foster, The Law Offices of Foster & Houston, Foster & Houston, FANDHLAW, FDA, Pradaxa, Pradaxa Lawsuit, Mechanical Heart Valves, Julie Foster, Juliet Foster, Harvard Health

FDA Warns of Possibly Permanent Nerve Damage from Fluoroquinolone Drugs

Posted by Firm Staff on Jan 12, 2017 6:31:40 PM
Antibacterial fluoroquinolone drugs could lead to serious side effects including peripheral neuropathy. Accordingly, the FDA issued a safety communication in 2013 requiring manufacturers to warn consumers about the risk of serious and possibly permanent nerve damage caused by this class of antibacterial drugs.
Read More

Topics: Fluoroquinolone, Fluoroquinolones, Levaquin, Avelox, FDA, Health, Medical Update, Levaquin Lawsuit, Avelox Lawsuit, FLQ, FLQ Lawsuit, Fluoroquinolone Lawsuit, Fluoroquinolones Lawsuit, Ryan Foster, Foster & Houston, The Law Offices of Foster & Houston, peripheral neuropathy, Juliet Foster, Julie Foster

Contact Foster & Houston

More to Read